Pfizer Raises $3.2 Billion by Selling Part of Haleon Stake
- Deal was upsized and priced at £3.80 per Haleon share
- US company has been selling down stake in Panadol maker
This article is for subscribers only.
Pfizer Inc. has raised about £2.4 billion ($3.2 billion) from the sale of Haleon Plc shares, as it further reduces its stake in the UK consumer health company.
The US pharmaceutical firm increased the number of shares to 640 million from 540 million after the sale had begun, according to terms of the deal seen by Bloomberg News. The oversubscribed offering was priced at £3.80 per share, a discount of about 3.3% to Monday’s close, according to a statement Tuesday.